Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by Skrit37on Sep 18, 2020 5:41am
120 Views
Post# 31579632

RE:RE:RE:RE:RE:RE:RE:Competition - Start With Step One

RE:RE:RE:RE:RE:RE:RE:Competition - Start With Step One
SAGDollar wrote: JHT said more that 1000 less than 3000 previously if I recall. I think 2000-2500 is an affordable yet realistic price.
brad129 wrote:

well I've seen people on here say they would pay $1000 but would you pay more? James did mention he wanted the price point so people could afford it, I think $5800 is a extremely high, I would rather they gave an introductory price, see how that subscribes then increase once we get a feel.



VerifiedUser123 wrote: Elephant in the room.

 





I also can not fully recall with certainty..but..I did an listen in interview around 1pmish about 4 plus months ago..and the interviewer asked him how much szls would charge for Aristotle....and im pretty sure he said it would be more the colon sentry at 375 but less then 2000.....something along the lines of he wanted to make sure it was widely affordable....wish i could remember even the interviewer...it was a spring of the moment interview that someone on the board posted an hour or so before it took place..... Goodluck folks!
Bullboard Posts